CA9 and colorectal carcinoma: To further characterize the affinity and specificity of radiolabeled CaIX-P1, competition experiments using the unlabeled peptide as competitor were carried out and the in vivo distribution of CaIX-P1 was evaluated in mice carrying subcutaneously transplanted colorectal carcinoma HCT116 tumors.